Moderna clinical trial: A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19

URL

Published Date

First posted July 14, 2020; last update January 12, 2023

Publication

National Library of Medicine

Organization

Moderna, Inc. and National Institute of Allergy and Infectious Diseases (NIAID)

Key Excerpts

“Actual Study Completion Date: December 29, 2022”

Medium

document

Topics

clinical trials,COVID-19,FDA approvals,mRNA,SARS-CoV-2 spike protein,manufacturers,vaccines